Trials / Completed
CompletedNCT00395148
Improving Metabolism With HDL Cholesterol
A Novel Mechanism Mediating Anti-atherosclerotic and Metabolic Actions of HDL Cholesterol
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Bayside Health · Other Government
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
High levels of good cholesterol (HDL) in our blood decreases our chance of having a heart attack. This relates in part to the role good cholesterol plays in reducing build up of fat in the arteries. However, good cholesterol has many other protective effects. We have recently identified three enzymes (proteins) activated by HDL in cells lining the blood vessels, which may be responsible for some of HDL's protective actions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | rHDL |
Timeline
- Start date
- 2006-03-01
- Primary completion
- 2008-03-01
- Completion
- 2008-03-01
- First posted
- 2006-11-02
- Last updated
- 2011-05-10
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT00395148. Inclusion in this directory is not an endorsement.